Evidence map›Paper›PMID 28602162›Full record

ArticleBMB reports2017

Endothelial miR-26a regulates VEGF-Nogo-B receptor-mediated angiogenesis.

Ha-Neul Jo, Hyesoo Kang, Aram Lee, Jihea Choi, Woochul Chang, Myeong-Sok Lee, Jongmin Kim

Open access · goldAbstract readNews
In one paragraph

Article in BMB reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Research advances on neurite outgrowth inhibitor B receptor.Journal of cellular and molecular medicine · 2020
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The regulatory role of microRNAs in angiogenesis-related diseases.Journal of cellular and molecular medicine · 2018
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ha-Neul JoDivision of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea.
Hyesoo KangDivision of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea.
Aram LeeDivision of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea.
Jihea ChoiDivision of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea.
Woochul ChangDepartment of Biology Education, College of Education, Pusan National University, Busan 46241, Korea.
Myeong-Sok LeeDivision of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea.
Jongmin KimDivision of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea.
Sookmyung Women's University · KRPusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Nogo-B receptor (NgBR) is necessary for not only Nogo-B-mediated angiogenesis but also vascular endothelial growth factor (VEGF) -induced angiogenesis. However, the molecular mechanisms underlying the regulatory role of the VEGF-NgBR axis in angiogenesis are not fully understood. Here, we report that miR-26a serves as a critical regulator of VEGF-mediated angiogenesis through directly targeting NgBR in endothelial cells (ECs). Stimulation of ECs by VEGF increased the expression of NgBR and decreased the expression of miR-26a. In addition, miR-26a decreased the VEGF-induced migration and proliferation of ECs. Moreover, miR-26a overexpression in ECs decreased the VEGF-induced phosphorylation of the endothelial nitric oxide synthase (eNOS) and the production of nitric oxide, which is important for angiogenesis. Overall, our data suggest that miR-26a plays a key role in VEGF-mediated angiogenesis through the modulation of eNOS activity, which is mediated by its ability to regulate NgBR expression by directly targeting the NgBR 3'-UTR. [BMB Reports 2017; 50(7): 384-389].

Indexed as

Neovascularization, PhysiologicCell ProliferationCells, CulturedEndothelial CellsHumansMicroRNAsNitric OxideReceptors, Cell SurfaceVascular Endothelial Growth FactorsMicroRNAsMIRN26 microRNA, humanNitric OxideNUS1 protein, humanReceptors, Cell SurfaceVascular Endothelial Growth Factors

Identifiers

PMID28602162
PMCPMC5584747
OpenAlexW2740776899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.